Cargando…

Glycemic variability and outcome in critically ill

BACKGROUND: Acute hyperglycemia, hypoglycemia and glycemic variability (GV) have been found to be the three principal domains of glycemic control, which can adversely affect patient outcome. GV may be the confounding factor in tight glycemic control trials in surgical and medical patient. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Todi, Subhash, Bhattacharya, Mahuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047689/
https://www.ncbi.nlm.nih.gov/pubmed/24914256
http://dx.doi.org/10.4103/0972-5229.132484
_version_ 1782480431933816832
author Todi, Subhash
Bhattacharya, Mahuya
author_facet Todi, Subhash
Bhattacharya, Mahuya
author_sort Todi, Subhash
collection PubMed
description BACKGROUND: Acute hyperglycemia, hypoglycemia and glycemic variability (GV) have been found to be the three principal domains of glycemic control, which can adversely affect patient outcome. GV may be the confounding factor in tight glycemic control trials in surgical and medical patient. OBJECTIVE: This study was conducted to establish if there was any relationship between GV and intensive care unit (ICU) mortality in the Indian context. STUDY DESIGN: A retrospective review of a large cohort of prospectively collected database. SETTING: Adult Medical/Surgical/Trauma/Neuro ICU of a tertiary care hospital. PATIENT POPULATION: All patients who had four or more blood glucose measured during the ICU stay. OUTCOME: ICU mortality. RESULT: 2208 patients with a total of 11,335 blood glucose values were analyzed. GV measured by the standard deviation (SD) of mean blood glucose and glycemic lability index (GLI), both were significantly (P < 0.001) associated with ICU mortality. This relationship was maintained (odds ratio (OR): 2.023, 95% confidence interval (CI): 1.483-2.758) even after excluding patients with hypoglycemia (<60 mg/dl). Patients with blood glucose values in the euglycemic range but highest SD had higher mortality (54%) compared to mortality (24%) in patients above the euglycemic range. Similarly patients with blood sugar values below the average for study cohort and high GLI, another marker of GV had higher mortality (OR: 5.62, CI: 3.865-8.198) than compared to patients in the hyperglycemic range, reflecting the importance of GV as a prognostic marker in patients with blood sugar in the euglycemic range. CONCLUSION: This study demonstrated that high glucose variability is associated with increased ICU mortality in a large heterogeneous cohort of ICU patients. This effect was particularly evident among patients in the euglycemic range.
format Online
Article
Text
id pubmed-4047689
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-40476892014-06-09 Glycemic variability and outcome in critically ill Todi, Subhash Bhattacharya, Mahuya Indian J Crit Care Med Research Article BACKGROUND: Acute hyperglycemia, hypoglycemia and glycemic variability (GV) have been found to be the three principal domains of glycemic control, which can adversely affect patient outcome. GV may be the confounding factor in tight glycemic control trials in surgical and medical patient. OBJECTIVE: This study was conducted to establish if there was any relationship between GV and intensive care unit (ICU) mortality in the Indian context. STUDY DESIGN: A retrospective review of a large cohort of prospectively collected database. SETTING: Adult Medical/Surgical/Trauma/Neuro ICU of a tertiary care hospital. PATIENT POPULATION: All patients who had four or more blood glucose measured during the ICU stay. OUTCOME: ICU mortality. RESULT: 2208 patients with a total of 11,335 blood glucose values were analyzed. GV measured by the standard deviation (SD) of mean blood glucose and glycemic lability index (GLI), both were significantly (P < 0.001) associated with ICU mortality. This relationship was maintained (odds ratio (OR): 2.023, 95% confidence interval (CI): 1.483-2.758) even after excluding patients with hypoglycemia (<60 mg/dl). Patients with blood glucose values in the euglycemic range but highest SD had higher mortality (54%) compared to mortality (24%) in patients above the euglycemic range. Similarly patients with blood sugar values below the average for study cohort and high GLI, another marker of GV had higher mortality (OR: 5.62, CI: 3.865-8.198) than compared to patients in the hyperglycemic range, reflecting the importance of GV as a prognostic marker in patients with blood sugar in the euglycemic range. CONCLUSION: This study demonstrated that high glucose variability is associated with increased ICU mortality in a large heterogeneous cohort of ICU patients. This effect was particularly evident among patients in the euglycemic range. Medknow Publications & Media Pvt Ltd 2014-05 /pmc/articles/PMC4047689/ /pubmed/24914256 http://dx.doi.org/10.4103/0972-5229.132484 Text en Copyright: © Indian Journal of Critical Care Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Todi, Subhash
Bhattacharya, Mahuya
Glycemic variability and outcome in critically ill
title Glycemic variability and outcome in critically ill
title_full Glycemic variability and outcome in critically ill
title_fullStr Glycemic variability and outcome in critically ill
title_full_unstemmed Glycemic variability and outcome in critically ill
title_short Glycemic variability and outcome in critically ill
title_sort glycemic variability and outcome in critically ill
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047689/
https://www.ncbi.nlm.nih.gov/pubmed/24914256
http://dx.doi.org/10.4103/0972-5229.132484
work_keys_str_mv AT todisubhash glycemicvariabilityandoutcomeincriticallyill
AT bhattacharyamahuya glycemicvariabilityandoutcomeincriticallyill